Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Decreased Body Temperature01:29

Decreased Body Temperature

1.2K
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.2K
Methods of reducing fever01:22

Methods of reducing fever

1.6K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.6K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

775
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
775

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Class I HD-ZIP transcription factor PagHB7a functions as a positive regulator of salt tolerance in <i>Populus</i>.

Forestry research·2026
Same author

Immunoprofiling by CyTOF Uncovers Disease-Defining Peripheral Immune Signatures and Mechanistic Links to Renal Injury in IgA Nephropathy.

Kidney diseases (Basel, Switzerland)·2026
Same author

Genetic Determinants of Steroid Responsiveness in IgA Nephropathy.

Journal of the American Society of Nephrology : JASN·2026
Same author

Effects of nitrogen-fixing plants on rhizosphere soil phosphorus contents at different soil nitrogen levels in subtropical karst forests.

Ying yong sheng tai xue bao = The journal of applied ecology·2025
Same author

Natural variation in PtobZIP18 confers the trade-off between stem growth and drought tolerance in Populus.

Plant biotechnology journal·2025
Same author

Ginsenoside Rg1 Restores Sirt2/Foxo1 Expression and Alleviates Autism-Like Behaviors in a Valproic Acid Induced Male Mouse Model.

The Kaohsiung journal of medical sciences·2025

Related Experiment Video

Updated: Apr 24, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

2.6K

Mild hypothermia in improving multiple organ dysfunction after cardiac arrest.

Lin Yang1, Xu-Ming Zhao1, Li-Jun Liu1

  • 1Department of Emergency and Critical Care Medicine, the Second Affiliated Hospital of Soochow University, Suzhou 215004, China.

World Journal of Emergency Medicine
|September 13, 2014
PubMed
Summary

Mild therapeutic hypothermia after cardiac arrest (CA) improves neurological and organ function. This treatment helps reduce multiple organ dysfunction syndrome (MODS) in patients who have been resuscitated.

Keywords:
Cardiac arrestIschemia reperfusion injuryMild hypothermiaMultiple organ dysfunction

More Related Videos

Establishment of Deep Hypothermic Circulatory Arrest in Rats
08:39

Establishment of Deep Hypothermic Circulatory Arrest in Rats

Published on: December 16, 2022

2.1K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

27.2K

Related Experiment Videos

Last Updated: Apr 24, 2026

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
08:22

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model

Published on: October 27, 2020

2.6K
Establishment of Deep Hypothermic Circulatory Arrest in Rats
08:39

Establishment of Deep Hypothermic Circulatory Arrest in Rats

Published on: December 16, 2022

2.1K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

27.2K

Area of Science:

  • Cardiology
  • Neurology
  • Critical Care Medicine

Background:

  • Cardiac arrest (CA) leads to ischemia-reperfusion injury, causing brain injury and multiple organ dysfunction syndrome (MODS).
  • Effective resuscitation strategies are crucial to mitigate post-CA organ damage.

Purpose of the Study:

  • To investigate the efficacy of mild systemic hypothermia in reducing multiple organ dysfunction following cardiac arrest resuscitation.
  • To compare outcomes in patients treated with therapeutic hypothermia versus standard normothermia.

Main Methods:

  • A review of patients resuscitated after cardiac arrest.
  • Patients were assigned to therapeutic hypothermia (32°C-34°C for 24-36 hours) or standard normothermia.
  • Organ injury markers were assessed for 72 hours post-ROSC (return of spontaneous circulation).

Main Results:

  • The hypothermia group showed favorable neurologic, myocardial, hepatic, and pulmonic outcomes at 72 hours post-ROSC.
  • Renal function did not significantly differ between the hypothermia and normothermia groups.
  • Blood coagulation function was impaired in the hypothermia group.

Conclusions:

  • Therapeutic mild hypothermia can alleviate organ dysfunction in successfully resuscitated cardiac arrest patients.
  • This intervention shows promise in improving post-resuscitation recovery, although coagulation effects require consideration.